1 More than 1.5 million people develop one of the most dangerous manifestations of SLE: lupus nephritis (LN), characterized by immune system induced inflammation of the kidneys. Within 10 years ...
More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...
Lupus nephritis is one of the most serious complications of systemic lupus erythematosus (SLE). It occurs when the immune system mistakenly attacks the kidneys, leading to inflammation and possibly to ...
1 The purpose of ALMS was to demonstrate the superiority of mycophenolate mofetil (MMF) over intravenous cyclophosphamide for the induction of remission in patients with lupus nephritis.
The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for ...
A minimum of 3 years of sustained clinical remission may protect against an increase in disease activity and the development ...
Lupus nephritis is a serious complication of lupus — and because it doesn’t always cause symptoms right away, it’s important to find it early. Talk to your lupus doctor about getting screened (tested) ...
Brad Rovin, MD: Thanks, Maureen. It's a real pleasure to be here. As you know, I love talking about lupus nephritis. Rovin: I work directly with KDIGO on glomerular disease guidelines. I had a ...
Learning the facts about lupus can mean the difference between early treatment and serious complications that impact quality of life.
The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro (obinutuzumab) as a treatment for lupus nephritis, with a decision expected in ...
Accelerating clinical path to commercialization in stiff person syndrome, myasthenia gravis and lupus nephritis Aligned with the U.S. Food ...
Adding obinutuzumab to standard therapy for active lupus nephritis led to significantly higher rates of complete renal response, according to data published in The New England Journal of Medicine.